About this trial
The study aims to identify a genotype/phenotype correlation by analyzing more finely the neurodevelopmental disorders in DMD patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
French citizenship, affiliated to the French Social Security,
5 to 12 years old,
DMD diagnosis confirmed by a genetic analysis predicting breaking in the reading frame of the DMD gene with knowledge of the limits of the mutation,
Follow-up in a French referral or a skills center belonging to Filnemus.
Disqualifiers
Severe intellectual deficiency with IQ < 55, and IQ < 70 for the deep neurocognitive evaluation (executive and socio-cognitive evaluation),
Cataract except if operated (pseudophakic),
High intraocular pressure,
Cardiac dysfunction with left ventricular ejection fraction < 35%,
Trial population
DMD diagnosis confirmed by a genetic analysis
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Nature and severity of sensory and neuropsychological disturbances
Specify the nature and severity of sensory and neuropsychological disturbances (cognitive, executive, emotional, behavioral and neuropsychiatric) according to the patient's genotype.
Secondary outcomes
Correlations between sensory and neuropsychological measures
Analyze the correlations between sensory (retinal/visual) and neuropsychological measures, in order to determine if retinal defects represent a signature of neuropsychological impairment severity.
Correlation between neuropsychological and functional imaging parameters
Analyze correlation between neuropsychological and functional imaging parameters.
Correlation between sensory and functional imaging parameters
Analyze correlation between sensory and functional imaging parameters.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.